274 related articles for article (PubMed ID: 27227569)
1. Role of DUSP1/MKP1 in tumorigenesis, tumor progression and therapy.
Shen J; Zhang Y; Yu H; Shen B; Liang Y; Jin R; Liu X; Shi L; Cai X
Cancer Med; 2016 Aug; 5(8):2061-8. PubMed ID: 27227569
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.
Kang Y; Nagaraja AS; Armaiz-Pena GN; Dorniak PL; Hu W; Rupaimoole R; Liu T; Gharpure KM; Previs RA; Hansen JM; Rodriguez-Aguayo C; Ivan C; Ram P; Sehgal V; Lopez-Berestein G; Lutgendorf SK; Cole SW; Sood AK
Clin Cancer Res; 2016 Apr; 22(7):1713-24. PubMed ID: 26581245
[TBL] [Abstract][Full Text] [Related]
3. DUSP1/MKP1 promotes angiogenesis, invasion and metastasis in non-small-cell lung cancer.
Moncho-Amor V; Ibañez de Cáceres I; Bandres E; Martínez-Poveda B; Orgaz JL; Sánchez-Pérez I; Zazo S; Rovira A; Albanell J; Jiménez B; Rojo F; Belda-Iniesta C; García-Foncillas J; Perona R
Oncogene; 2011 Feb; 30(6):668-78. PubMed ID: 20890299
[TBL] [Abstract][Full Text] [Related]
4. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
5. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
[TBL] [Abstract][Full Text] [Related]
6. DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer.
Shen J; Zhou S; Shi L; Liu X; Lin H; Yu H; Xiaoliang ; Tang J; Yu T; Cai X
Oncotarget; 2017 Feb; 8(7):12133-12144. PubMed ID: 28129656
[TBL] [Abstract][Full Text] [Related]
7. Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues.
Melhem A; Yamada SD; Fleming GF; Delgado B; Brickley DR; Wu W; Kocherginsky M; Conzen SD
Clin Cancer Res; 2009 May; 15(9):3196-204. PubMed ID: 19383827
[TBL] [Abstract][Full Text] [Related]
8. MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.
Wei X; Tang C; Lu X; Liu R; Zhou M; He D; Zheng D; Sun C; Wu Z
Oncotarget; 2015 Jul; 6(21):18389-405. PubMed ID: 26158762
[TBL] [Abstract][Full Text] [Related]
9. DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer.
Teng F; Xu Z; Chen J; Zheng G; Zheng G; Lv H; Wang Y; Wang L; Cheng X
Oncol Rep; 2018 Sep; 40(3):1203-1222. PubMed ID: 29956792
[TBL] [Abstract][Full Text] [Related]
10. USP49 inhibits ischemia-reperfusion-induced cell viability suppression and apoptosis in human AC16 cardiomyocytes through DUSP1-JNK1/2 signaling.
Zhang W; Zhang Y; Zhang H; Zhao Q; Liu Z; Xu Y
J Cell Physiol; 2019 May; 234(5):6529-6538. PubMed ID: 30246457
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase.
Korhonen R; Turpeinen T; Taimi V; Nieminen R; Goulas A; Moilanen E
Mol Immunol; 2011 Sep; 48(15-16):2059-68. PubMed ID: 21764456
[TBL] [Abstract][Full Text] [Related]
12. Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids.
Maier JV; Brema S; Tuckermann J; Herzer U; Klein M; Stassen M; Moorthy A; Cato AC
Mol Endocrinol; 2007 Nov; 21(11):2663-71. PubMed ID: 17636038
[TBL] [Abstract][Full Text] [Related]
13. DUSP1 phosphatase regulates the proinflammatory milieu in head and neck squamous cell carcinoma.
Zhang X; Hyer JM; Yu H; D'Silva NJ; Kirkwood KL
Cancer Res; 2014 Dec; 74(24):7191-7. PubMed ID: 25312268
[TBL] [Abstract][Full Text] [Related]
14. MAP kinase phosphatase DUSP1 is overexpressed in obese humans and modulated by physical exercise.
Khadir A; Tiss A; Abubaker J; Abu-Farha M; Al-Khairi I; Cherian P; John J; Kavalakatt S; Warsame S; Al-Madhoun A; Al-Ghimlas F; Elkum N; Behbehani K; Dermime S; Dehbi M
Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E71-83. PubMed ID: 25370852
[TBL] [Abstract][Full Text] [Related]
15. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
16. Enhanced MAPK signaling induced by CSF3R mutants confers dependence to DUSP1 for leukemic transformation.
Kesarwani M; Kincaid Z; Azhar M; Azam M
Blood Adv; 2024 Jun; 8(11):2765-2776. PubMed ID: 38531054
[TBL] [Abstract][Full Text] [Related]
17. Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy.
Wang J; Zhou JY; Kho D; Reiners JJ; Wu GS
Autophagy; 2016 Oct; 12(10):1791-1803. PubMed ID: 27459239
[TBL] [Abstract][Full Text] [Related]
18. Puerarin promotes DUSP1 expression by regulating miR‑133a‑3p in breast cancer.
Li Z; Xu W; Ren X; Xu J; Chen J
Mol Med Rep; 2019 Jan; 19(1):205-212. PubMed ID: 30483784
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-Dependent Regulation of DUSP1 Governs ERK and p38 Signaling During Early 3T3-L1 Adipocyte Differentiation.
Ferguson BS; Nam H; Stephens JM; Morrison RF
J Cell Physiol; 2016 Jul; 231(7):1562-74. PubMed ID: 26566083
[TBL] [Abstract][Full Text] [Related]
20. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
